View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Astrix
3 June 2022

Astrix Adds Veteran Life Science IT Executive Leadership to the Board of Directors

Astrix, the market leader in strategic, technical and staffing services for life science organisations, announced today the appointment of Sandy Tremps to its board of directors. Sandy is a successful industry veteran bringing over 30 years of life sciences IT leadership to Astrix.

“Digital transformation remains a top priority for the life sciences industry and that’s not changing anytime soon,” said Dale Curtis, CEO of Astrix. “There’s no better way to drive value for clients than having a successful executive helping guide strategic direction at Astrix. We’re excited to have a wildly successful industry veteran like Sandy on board and look forward to her insights & contributions.”

Sandy’s experience spans many aspects of IT, including delivery, strategic planning, portfolio management, compliance, and process management. She joined Merck & Co in 1988 and led IT organisations across multiple divisions and spanning critical programmes in support of Merck Research Laboratories (MRL) Global Development, MRL Pre-Clinical, Global Human Health (GHH) Emerging Markets, Merck Manufacturing Division (MMD) IT Automation and MMD Project 2000. She served as divisional CIO for Merck Research Laboratories from 2016-2021.

“Astrix has created a unique one-stop-shop where they deliver the people, processes, and a technology agnostic approach to solve the most complex challenges for life sciences companies,” said Sandy Tremps. “I’m excited to share my expertise and insights to help fine-tune Astrix’s strategy so that we can continue to deliver the highest level of value for clients.”

Sandy’s appointment to the Astrix Board of Directors is effective as of 1 May 2022.

Bioinformatics is one of the most rapidly evolving tools for accelerating life science research and biopharmaceutical development.
The emergence of cloud based computing, artificial intelligence (AI), machine learning (ML) applications and SMART technology necessitate a paradigm shift in the current approach to...
In the quest to attain the digitally connected laboratory of the future, organizations are faced with seemingly insurmountable decisions regarding the scope and strategy that...
Accelerated drug development is being driven by increased market competition, downward price pressures, and growing complexity of regulatory reporting requirements. These, and other market factors,...
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology